Daniel W A, Wójcikowski J
Polish Academy of Sciences, Institute of Pharmacology, Kraków, Poland.
Pharmacol Toxicol. 1997 Feb;80(2):62-8. doi: 10.1111/j.1600-0773.1997.tb00285.x.
The present study was aimed at assessing individual contributions of the phospholipid binding and lysosomal trapping to the total tissue uptake of psychotropic drugs with different chemical structures, such as promazine, imipramine, amitriptyline, fluoxetine, sertraline (basic lipophilic drugs) and carbamazepine (lipophilic, but not basic). We also tried to find out whether lysosomal trapping may be involved in the pharmacokinetic interactions in clinical combinations of psychotropics. Uptake experiments were carried out on slices of various rat tissues as a system with intact lysosomes. Initial concentration of each drug was 5 microM. The results were compared with those obtained in the presence of the "lysosomal inhibitors", ammonium chloride or monensin. The basic lipophilic psychotropics showed high uptake in tissues known for the abundance of lysosomes, mainly the lungs. The highest drug accumulation was found for promazine and amitriptyline. "Lysosomal inhibitors" significantly decreased the uptake of the basic lipophilic drugs, particularly in the lungs and liver. The most potent effect was observed for amitriptyline, imipramine and promazine. The brain showed moderate accumulation of basic lipophilic psychotropics and the effect of the "lysosomal inhibitors" was significant only in the case of amitriptyline, imipramine and sertraline. The only exception to the above regularity were imipramine and sertraline which were taken up more extensively by the adipose tissue than by lysosome-rich tissues such as the lungs or liver. Carbamazepine did not show lysosomotropism. Amitriptyline and promazine mutually decreased their uptake by lung slices when the drugs were incubated jointly. In the presence of ammonium chloride the interaction did not occur. In conclusion, the obtained results show that (1) the lysosomal trapping is an important factor determining the distribution of the basic lipophilic psychotropics; however (2) their tissue uptake depends more on the phospholipid binding than on the lysosomal trapping; (3) the lysosomal trapping may be involved in the pharmacokinetic interactions between psychotropics.
本研究旨在评估磷脂结合和溶酶体捕获对不同化学结构的精神药物(如丙嗪、丙咪嗪、阿米替林、氟西汀、舍曲林(碱性亲脂性药物)和卡马西平(亲脂性,但非碱性))在组织中的总摄取量的个体贡献。我们还试图探究溶酶体捕获是否可能参与精神药物临床联合用药时的药代动力学相互作用。以具有完整溶酶体的各种大鼠组织切片为体系进行摄取实验。每种药物的初始浓度为5微摩尔。将结果与在存在“溶酶体抑制剂”氯化铵或莫能菌素的情况下获得的结果进行比较。碱性亲脂性精神药物在以溶酶体丰富而闻名的组织(主要是肺)中显示出高摄取量。丙嗪和阿米替林的药物积累量最高。“溶酶体抑制剂”显著降低了碱性亲脂性药物的摄取,尤其是在肺和肝脏中。对阿米替林、丙咪嗪和丙嗪观察到最显著的效果。脑显示出碱性亲脂性精神药物的中度积累,并且“溶酶体抑制剂”的作用仅在阿米替林、丙咪嗪和舍曲林的情况下显著。上述规律的唯一例外是丙咪嗪和舍曲林,它们在脂肪组织中的摄取比在富含溶酶体的组织(如肺或肝脏)中更广泛。卡马西平未表现出溶酶体趋向性。当联合孵育药物时,阿米替林和丙嗪相互降低了它们在肺切片中的摄取。在氯化铵存在的情况下,这种相互作用未发生。总之,所获得的结果表明:(1)溶酶体捕获是决定碱性亲脂性精神药物分布的一个重要因素;然而(2)它们在组织中的摄取更多地取决于磷脂结合而不是溶酶体捕获;(3)溶酶体捕获可能参与精神药物之间的药代动力学相互作用。